文献速递垂体与肾上腺疾病

美国明尼苏达州奥姆斯特德县肾上腺肿瘤流行病学:基于人群的队列研究

Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study.
PubMed 文献 · Lancet Diabetes Endocrinol · 2020-01-01

该研究基于罗切斯特流行病学项目,评估1995至2017年奥姆斯特德县肾上腺肿瘤的标准化发病率、患病率及恶性与激素分泌异常比例。

要点

  • 肾上腺肿瘤标准化发病率17年间增加约10倍,主要因>40岁患者<40mm腺瘤的偶然发现。
  • 2017年患病率532/10万,儿童13/10万,>65岁者达1900/10万。

核心结论

  • 基于人群的数据显示恶性、嗜铬细胞瘤和明显激素过剩的比例低于既往报道。

研究设计与样本

  • 回顾性基于人群的队列研究,纳入1995年1月1日至2017年12月31日居住于奥姆斯特德县的所有肾上腺肿瘤患者。
  • 利用罗切斯特流行病学项目链接全县所有医疗机构的病历,发病率与患病率按2010年美国人口年龄和性别标准化。

主要发现

  • 2017年患病率为532/10万,儿童(<18岁)为13/10万,>65岁患者为1900/10万。

临床怎么用

  • 在普通人群中,肾上腺肿瘤多为偶然发现的良性小腺瘤,恶性及功能亢进比例较低。
  • 评估肾上腺肿瘤时需结合大小、影像特征(平扫CT衰减)、双侧性及发现背景(癌症分期/随访)判断恶性风险。
  • 儿童患者肾上腺肿瘤恶性比例高,应予以更积极评估。

局限性

  • 回顾性研究设计,可能存在诊断和记录偏倚。
  • 研究人群为单一地理区域,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Adrenal tumours are commonly encountered in clinical practice, but epidemiological data mainly originate from referral centres. We aimed to determine incidence, prevalence, and rates of malignancy and hormone excess in patients with adrenal tumours in a standardised geographically well defined population. METHODS: In this retrospective population-based cohort study we assessed the standardised incidence rate of adrenal tumours in all patients with tumours who lived in Olmsted County, MN, USA, from Jan 1, 1995, to Dec 31, 2017. The Rochester Epidemiology Project infrastructure, which links medical records across all health-care providers for the entire population of Olmsted County since 1966, was used to allow researchers to identify individuals with specific diagnoses, surgical interventions, and other procedures, and to locate their medical records, which were then used in the analysis. Incidence rates and prevalence were standardised for age and sex according to the 2010 US Population. FINDINGS: An adrenal tumour was diagnosed in 1287 patients (median age 62 years; 713 (55·4%) were women; and 13 (1·0%) were children). Standardised incidence rates increased from 4·4 (95% CI 0·3-8·6) per 100 000 person-years in 1995 to 47·8 (36·9-58·7) in 2017, mainly because of the incidental discovery of adenomas less than 40 mm in diameter in patients older than 40 years. Prevalence of adrenal tumours in 2017 was 532 per 100 000 inhabitants, ranging from 13 per 100 000 in children (aged <18 years) to 1900 per 100 000 in patients older than 65 years. 111 (8·6%) of 1287 patients were diagnosed with malignancy (96 [7·5%] of whom has metastases), 14 (1·1%) with phaeochromocytoma, and 53 (4·1%) with overt steroid hormone excess. Malignancy was more common in children (62%) versus those older than 18 years (8%; p<0·0001), tumours discovered during cancer-staging or follow-up (43% vs 3% for incidentalomas; p<0·0001), tumours more than 40 mm in diameter (34% vs 6% for tumours <20 mm; p<0·0001), tumours with unenhanced CT attenuation of 30 Hounsfield units or more (20% vs 1% for <20 Hounsfield units; p<·0001), and bilateral masses (16% vs 7% for unilateral, p=0·0004). INTERPRETATION: Adrenal tumour standardised incidence rates increased 10 times from 1995 to 2017. Population-based data revealed lower rates of malignancy, phaeochromocytoma, and overt steroid hormone excess than previously reported. FUNDING: National Institutes of Health.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Ebbehoj A, Li D, Kaur RJ, et al. Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study. Lancet Diabetes Endocrinol. 2020. PMID: 33065059. doi:10.1016/S2213-8587(20)30314-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。